
Kristin Davenport
Professional Bio
Kristin Davenport advises medical device companies regarding premarket strategies and pathways, the premarket submission process, advertising and promotion, compliance and enforcement matters, and import/export issues.
She has extensive experience with 510(k) premarket notifications, de novo petitions, premarket approval applications, investigational device exemptions, device modifications, 513(g) Requests for Information, MDR reporting, device recalls, and Part 806 reports.
5 Reasons Digital Solutions for Women+ Health Will Grow in 2023
Covington Digital Health ·
5 Digital Health Issues to Watch at FDA in 2022
Covington Digital Health ·